Leslie A. Parsels

2.7k total citations
39 papers, 2.1k citations indexed

About

Leslie A. Parsels is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Leslie A. Parsels has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 29 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Leslie A. Parsels's work include DNA Repair Mechanisms (19 papers), Cancer-related Molecular Pathways (9 papers) and PARP inhibition in cancer therapy (9 papers). Leslie A. Parsels is often cited by papers focused on DNA Repair Mechanisms (19 papers), Cancer-related Molecular Pathways (9 papers) and PARP inhibition in cancer therapy (9 papers). Leslie A. Parsels collaborates with scholars based in United States, New Zealand and Brazil. Leslie A. Parsels's co-authors include Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan, Joshua D. Parsels, Lili Zhao, Mary A. Davis, Christine E. Canman, David Karnak, Daniel P. Normolle and Sonya Zabludoff and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Leslie A. Parsels

39 papers receiving 2.1k citations

Peers

Countries citing papers authored by Leslie A. Parsels

Since Specialization

Citations

This map shows the geographic impact of Leslie A. Parsels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie A. Parsels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie A. Parsels more than expected).

Fields of papers citing papers by Leslie A. Parsels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie A. Parsels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie A. Parsels. The network helps show where Leslie A. Parsels may publish in the future.

Co-authorship network of co-authors of Leslie A. Parsels

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie A. Parsels. A scholar is included among the top collaborators of Leslie A. Parsels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie A. Parsels. Leslie A. Parsels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer 2024 ·JCI Insight ·(unknown), Long Jiang, Weiwei Wang, Amanda K. Huber, (unknown), (unknown), Erin A. Holcomb, (unknown), Stephanie The, Zhuwen Wang, Leslie A. Parsels, Joshua D. Parsels, Daniel Wahl, Arvind Rao, Vaibhav Sahai, Theodore S. Lawrence, Michael D. Green, Meredith A. Morgan	7
2	Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma 2023 ·Neoplasia ·Leslie A. Parsels, Daniel Wahl, Carl Koschmann, Meredith A. Morgan, (unknown)	5
3	Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner 2021 ·Molecular Cancer Research ·Kailiang Zhao, Qiang Zhang, (unknown), Xueting Lang, Long Jiang, Leslie A. Parsels, Joshua D. Parsels, Weiping Zou, Theodore S. Lawrence, Rémi Buisson, Michael D. Green, Meredith A. Morgan	10
4	Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer 2020 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Carl G. Engelke, Joshua D. Parsels, (unknown), Qiang Zhang, Daria M. Tanska, Daniel Wahl, Christine E. Canman, Theodore S. Lawrence, Meredith A. Morgan	29
5	Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy 2019 ·Cancer Research ·Qiang Zhang, Michael D. Green, Xueting Lang, Jenny Lazarus, Joshua D. Parsels, Shuang Wei, Leslie A. Parsels, Jiaqi Shi, Nithya Ramnath, Daniel Wahl, Marina Pasca di Magliano, Timothy L. Frankel, Ilona Kryczek, Yu L. Lei, Theodore S. Lawrence, Weiping Zou, Meredith A. Morgan	150
6	PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors 2017 ·Molecular Cancer Research ·Leslie A. Parsels, David Karnak, Joshua D. Parsels, Qiang Zhang, (unknown), Zachery R. Reichert, Daniel Wahl, Jonathan Maybaum, Mark J. O’Connor, Theodore S. Lawrence, Meredith A. Morgan	98
7	Targeting Mcl-1 for Radiosensitization of Pancreatic Cancers 2015 ·Translational Oncology ·Dongping Wei, Qiang Zhang, (unknown), Leslie A. Parsels, Fardokht A. Abulwerdi, Tasneem Kausar, Theodore S. Lawrence, Yi Sun, Zaneta Nikolovska‐Coleska, Meredith A. Morgan	23
8	Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer 2014 ·Clinical Cancer Research ·David Karnak, Carl G. Engelke, Leslie A. Parsels, Tasneem Kausar, Dongping Wei, (unknown), (unknown), Mary A. Davis, Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	125
9	Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair 2013 ·Clinical Cancer Research ·Dongping Wei, Leslie A. Parsels, David Karnak, Mary A. Davis, Joshua D. Parsels, (unknown), Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Yi Sun, Meredith A. Morgan	80
10	Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776 2013 ·Clinical Cancer Research ·Carl G. Engelke, Leslie A. Parsels, Yushen Qian, Qiang Zhang, David Karnak, (unknown), Daria M. Tanska, Dongping Wei, Mary A. Davis, Joshua D. Parsels, Lili Zhao, Joel K. Greenson, Theodore S. Lawrence, Jonathan Maybaum, Meredith A. Morgan	89
11	Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition 2012 ·Neoplasia ·Venkatasubbaiah A. Venkatesha, Leslie A. Parsels, Joshua D. Parsels, Lili Zhao, Sonya Zabludoff, Diane M. Simeone, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	73
12	Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition 2011 ·Clinical Cancer Research ·Leslie A. Parsels, Yushen Qian, Daria M. Tanska, (unknown), Lili Zhao, Maria Hassan, Sankari Arumugarajah, Joshua D. Parsels, Linda Hylander-Gans, Diane M. Simeone, Deborah Morosini, Jeffrey L. Brown, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	67
13	Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1 2011 ·Cell Cycle ·Sean Vance, Erqi Liu, Lili Zhao, Joshua D. Parsels, Leslie A. Parsels, (unknown), Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	70
14	Bayesian Hierarchical Changepoint Methods in Modeling the Tumor Growth Profiles in Xenograft Experiments 2010 ·Clinical Cancer Research ·Lili Zhao, Meredith A. Morgan, Leslie A. Parsels, Jonathan Maybaum, Theodore S. Lawrence, Daniel P. Normolle	26
15	Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair 2010 ·Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, Lili Zhao, Joshua D. Parsels, Mary A. Davis, Maria Hassan, Sankari Arumugarajah, Linda Hylander-Gans, Deborah Morosini, Diane M. Simeone, Christine E. Canman, Daniel P. Normolle, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence	249
16	Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells 2009 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Meredith A. Morgan, Daria M. Tanska, Joshua D. Parsels, Brian D. Palmer, R J Booth, William A. Denny, Christine E. Canman, Alan J. Kraker, Theodore S. Lawrence, Jonathan Maybaum	120
17	The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer 2008 ·Clinical Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, (unknown), Daniel P. Normolle, Jonathan Maybaum, Theodore S. Lawrence	99
18	5-Fluoro-2′-Deoxyuridine-Induced cdc25A Accumulation Correlates with Premature Mitotic Entry and Clonogenic Death in Human Colon Cancer Cells 2004 ·Cancer Research ·Leslie A. Parsels, Joshua D. Parsels, (unknown), Daniel J. Coughlin, Jonathan Maybaum	18
19	Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells 1998 ·Cancer Chemotherapy and Pharmacology ·Leslie A. Parsels, Joshua D. Parsels, (unknown), (unknown), Eric H. Radany, Jonathan Maybaum	22
20	Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype 1997 ·Molecular Pharmacology ·Leslie A. Parsels, Richard C. Zellars, (unknown), Joshua D. Parsels, Michael F. Clarke, (unknown), Theodore S. Lawrence, Jonathan Maybaum	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact